What tool or method do you wish existed?
- PMID: 39178826
- DOI: 10.1016/j.cell.2024.07.043
What tool or method do you wish existed?
Abstract
We asked researchers from a range of disciplines across biology, engineering, and medicine to describe a current technological need. The goal is to provide a sample of the various technological gaps that exist and inspire future research projects.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests Y.Y.C. is an inventor of several patents related to CAR T cell therapies; is a founder of, holds equity in, and receives consulting fees from ImmPACT Bio; and is a member of the scientific advisory board of and holds stock options in Notch Therapeutics, Pluto Immunotherapeutics, Prime Medicine, Sonoma Biotherapeutics, Waypoint Bio, and AffyImmune. M.M. is the director of the proteomics program at CPR, Faculty of Health and Medical Sciences, University of Copenhagen, and an indirect investor in Evosep. H.R.U. is a co-inventor on a patent and patent applications covering the CUBIC reagents (PCT/JP2014/070618; PCT/JP2017/016410) and a cofounder of CUBICStars Inc. M.M.-N. is chair of the Advisory Committee for the Max Planck Institute for Biology, Tuebingen, Germany, 2024–2027; a member of the Advisory Committee for NIH COBRE grant, U Hawaii, 2023–2028; a member of the Hypothesis Fund Advisory Committee, as of 2022; a member of the Burroughs Wellcome Fund’s Climate Change & Human Health Advisory Committee, as of 2022; a member, of the advisory board for the Carl Woese Center for Genomics REsearcg, University of Illinois, Urbana-Champaign, as of 2020; and a member of the advisory board for the Collaborative Research Center, German Research Foundation, “Origin and Function of Metaorganisms,” as of 2015.